Tranexamic Acid (TXA) in Trauma Patients: Barriers to Use among Trauma Surgeons and Emergency Physicians
Objective. Tranexamic Acid (TXA) is currently the only drug with prospective clinical evidence supporting its use in bleeding trauma patients. We sought to better understand the barriers preventing its use and elicit suggestions to further its use in trauma patients in the state of Maryland. Methods...
Saved in:
| Main Author: | Abdulaziz Alburaih |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2017-01-01
|
| Series: | Emergency Medicine International |
| Online Access: | http://dx.doi.org/10.1155/2017/4235785 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
TXA (Tranexamic Acid) Risk Evaluation in Combat Casualties (TRECC)
by: Kathleen E Adair, et al.
Published: (2020-12-01) -
First-line pembrolizumab used concurrently with multi-agent chemotherapy and inhaled tranexamic acid (TXA) for management of stage III mixed trophoblastic tumor complicated by pulmonary hemorrhage
by: Rose Emlein, et al.
Published: (2025-06-01) -
Prehospital tranexamic acid decreases early mortality in trauma patients: a systematic review and meta-analysis
by: Yi Li, et al.
Published: (2025-03-01) -
Angioembolization performed by trauma surgeons for trauma patients: is it feasible in Korea? A retrospective study
by: Soonseong Kwon, et al.
Published: (2024-03-01) -
Role of Trauma Surgeons at a Regional Trauma Center in South Korea
by: Dongmin Seo, et al.
Published: (2024-11-01)